Comparison of Treatment Methods of Primary Obstructive Megaureter

Yıl 2023, , 187 - 191, 20.10.2023

Fatma Özcan Sıkı , Mehmet Sarıkaya , Metin Gündüz , Tamer Sekmenli , İlhan Çiftci , İsa Yılmaz , Harun Peru

https://doi.org/10.56766/ntms.1358523

Öz

BACKGROUND: Primary megaureter (PM) is a common congenital uropathy. In this study, we compared the results of treatment options for primary megaureter with obstruction in UVJ.
METHODS: The files of all patients who underwent open surgery and had a double J (JJ) ureteral stent for treating primary obstructive megaureter in our institution between 2010 and 2023 were evaluated retrospectively. The demographic information of the patients, the results of imaging tests before and after the surgery, early and late complications after the treatment, and the length of stay in the hospital were recorded. The results of both treatment methods were compared statistically.
RESULTS: A total of 23 patients and 26 kidney units over 13 years were retrospectively analyzed. Eighteen patients were male (78%); 5 were girls (22%). Ureteral tapering and ureteroneocystostomy (UNC) were performed with open surgery in 8 patients, while JJ stent was placed in 12 patients primarily by cystoscopy. In the urinary system ultrasonography (USS) performed at an average of 3 months after the treatment, hydronephrosis grades were observed to regress in 25 units. All patients recovered after surgery and there was no significant difference between the two treatment methods (p> 0.05).
CONCLUSION: In the treatment of primary obstructive megaureter (POM), endoscopic JJ stenting is as effective as ureteral reimplantation with open surgery. It may be considered more valuable due to the shorter hospital stay

Anahtar Kelimeler

double J stent, primary obstructive megaureter, pediatric patient, ureteroneocystostomy

Etik Beyan

Ethics committee approval was obtained from the Selcuk University Faculty of Medicine Local Ethics Committee for this study (2021/252).

Destekleyen Kurum

This work has not received external funding. None of the authors have financial statements to declare.

Proje Numarası

1

Teşekkür

non

Kaynakça

• 1. Buder K, Opherk K, Mazzi S, Rohner K, Weitz M. Non-surgical management in children with non-refluxing primary megaureter: a systematic review and meta-analysis. Pediatr Nephrol. 2023; 38(11):3549-58. 2. Keating MA, Escala J, Snyder HM 3rd, Heyman S, Duckett JW. Changing concepts in management of primary obstructive megaureter. J Urol. 1989; 142(2 Pt 2):636-68.
• 3. Carroll D, Chandran H, Joshi A, McCarthy LS, Parashar K. Endoscopic placement of double-J ureteric stents in children as a treatment for primary obstructive megaureter. Urol Ann. 2010; 2(3):114-18.
• 4. Andriole GL, Bettmann MA, Garnick MB, Richie JP. Indwelling double-J ureteral stents for temporary and permanent urinary drainage: experience with 87 patients. J Urol. 1984; 131(2):239-41.
• 5. Barbancho DC, Fraile AG, Sánchez RT, et al. Es util el manejo inicial del megauré6ter primario con catéteres doble J? [Is effective the initial management of primary nonrefluxing megaureter with double-J stent?]. Cir Pediatr. 2008; 21(1):32-36.
• 6. Casal Beloy I, Somoza Argibay I, García González M, García Novoa MA, Míguez Fortes LM, Dargallo Carbonell T. Endoscopic balloon dilatation in primary obstructive megaureter: Long-term results. J Pediatr Urol. 2018; 14(2):167.e1-167.e5.
• 7. Kassite I, Renaux Petel M, Chaussy Y, et al. High Pressure Balloon Dilatation of Primary Obstructive Megaureter in Children: A Multicenter Study. Front Pediatr. 2018; 6:329.
• 8. García-Aparicio L, Blázquez-Gómez E, Martin O, et al. Use of high-pressure balloon dilatation of the ureterovesical junction instead of ureteral reimplantation to treat primary obstructive megaureter: is it justified?. J Pediatr Urol. 2013; 9(6 Pt B):1229-33.
• 9. Romero RM. Management of Primary Obstructive Megaureter by Endoscopic High-Pressure Balloon Dilatation. IDEAL Framework Model as a New Tool for Systematic Review. Front Surg. 2019; 6:20.
• 10. Ortiz R, Parente A, Perez-Egido L, Burgos L, Angulo JM. Long-Term Outcomes in Primary Obstructive Megaureter Treated by Endoscopic Balloon Dilation. Experience After 100 Cases. Front Pediatr. 2018; 6:275.
• 11. Awad K, Woodward MN, Shalaby MS. Long-term outcome of JJ stent insertion for primary obstructive megaureter in children. J Pediatr Urol. 2019; 15(1):66.e1-66.e5.
• 12. Shenoy MU, Rance CH. Is there a place for the insertion of a JJ stent as a temporizing procedure for symptomatic partial congenital vesico-ureteric junction obstruction in infancy?. BJU Int. 1999; 84(4):524-25.
• 13. Jude E, Deshpande A, Barker A, Khosa J, Samnakay N. Intravesical ureteric reimplantation for primary obstructed megaureter in infants under 1 year of age. J Pediatr Urol. 2017; 13(1):47.e1-47.e7.
• 14. Shrestha AL, Bal HS, Kisku SMC, Sen S. Outcome of end cutaneous ureterostomy (ECU) as a non conservative option in the management of primary obstructive megaureters (POM). J Pediatr Urol. 2018; 14(6):541.e1-541.e5.
• 15. Castagnetti M, Cimador M, Sergio M, De Grazia E. Double-J stent insertion across vesicoureteral junction--is it a valuable initial approach in neonates and infants with severe primary nonrefluxing megaureter?. Urology. 2006; 68(4):870-76.